Literature DB >> 33372683

Are Infants and Toddlers with Moderate-to-severe Atopic Dermatitis Undertreated? Experiences of a Finnish Tertiary Care Hospital.

Andreas Antti1, Alexander Salava, Miia Perälä, Anna S Pelkonen, Mika J Mäkelä, Anita Remitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33372683      PMCID： PMC9309851          DOI： 10.2340/00015555-3739

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  16 in total

1.  Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.

Authors:  Anita Remitz; John Harper; Malcolm Rustin; Wouter F M Goldschmidt; Riitta Palatsi; Pieter G M van der Valk; Graham Sharpe; Catherine H Smith; Attila Dobozy; Kristiina Turjanmaa
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

2.  Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study.

Authors:  Sandra Moawad; Emmanuel Mahé; Hélène Aubert-Wastiaux; Alice Phan; Annabel Maruani; Christine Chiaverini; Christine Bodemer; Juliette Mazereeuw-Hautier; Audrey Lasek-Duriez; Catherine Droitcourt; Sébastien Barbarot; Alain Beauchet; Anne-Claire Bursztejn
Journal:  Am J Clin Dermatol       Date:  2018-04       Impact factor: 7.403

Review 3.  The impact of pediatric atopic dermatitis on families: A review.

Authors:  Eric J Yang; Kristen M Beck; Sahil Sekhon; Tina Bhutani; John Koo
Journal:  Pediatr Dermatol       Date:  2018-12-16       Impact factor: 1.588

4.  Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study.

Authors:  Johanna M Mandelin; Andris Rubins; Anita Remitz; Kristine Cirule; James Dickinson; Vincent Ho; Mika J Mäkelä; Silvestrs Rubins; Sakari Reitamo; Nasrullah Undre
Journal:  Int J Dermatol       Date:  2011-09-19       Impact factor: 2.736

5.  The Burden of Moderate to Severe Atopic Dermatitis in Canadian Children: A Cross-Sectional Survey.

Authors:  Alanna C Bridgman; Panteha Eshtiaghi; Amanda Cresswell-Melville; Michele Ramien; Aaron M Drucker
Journal:  J Cutan Med Surg       Date:  2018 Jul/Aug       Impact factor: 2.092

Review 6.  Update on topical glucocorticoid use in children.

Authors:  Keith W Morley; James G Dinulos
Journal:  Curr Opin Pediatr       Date:  2012-02       Impact factor: 2.856

Review 7.  Optimizing outcomes for paediatric atopic dermatitis.

Authors:  L F Eichenfield; C Totri
Journal:  Br J Dermatol       Date:  2014-05-09       Impact factor: 9.302

Review 8.  A comparison of international management guidelines for atopic dermatitis.

Authors:  Lindsey M LePoidevin; Dylan E Lee; Vivian Y Shi
Journal:  Pediatr Dermatol       Date:  2018-10-10       Impact factor: 1.588

9.  Different potencies of topical corticosteroids for a better treatment strategy in children with atopic dermatitis (the Rotterdam Eczema study): protocol for an observational cohort study with an embedded randomised open-label controlled trial.

Authors:  Karlijn F van Halewijn; Arthur M Bohnen; Pieter J van den Berg; Suzanne G M A Pasmans; Patrick J E Bindels; Gijs Elshout
Journal:  BMJ Open       Date:  2019-06-19       Impact factor: 2.692

Review 10.  Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Jennifer D Kaiser; Adelaide A Hebert
Journal:  BMC Pediatr       Date:  2016-06-07       Impact factor: 2.125
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.